Highlights: * XPON Technologies set to trade on the ASX today from 12.00 PM AEDT * Oversubscrib...
* QBiotics commences the Australian commercial launch of its lead veterinary drug, STELFONTA®, wh...
SYDNEY, Dec. 2, 2021 /PRNewswire/ -- EZZ Life Science Holdings Limited (ASX: EZZ), a genomic life s...
SYDNEY, Nov. 23, 2021 /PRNewswire/ -- EZZ Life Science Holdings Limited (ASX: EZZ),an Australian ge...
* Race Oncology's drug Zantrene shown to protect human heart muscle cells from anthracycline-indu...
SYDNEY, Nov. 11, 2021 /PRNewswire/ -- From November 5 to 10, the 4th China International ImportExpo...
SYDNEY, Nov. 4, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncolo...
About EZZ Life Science Holdings EZZ Life Science Holding Limited (ASX:EZZ) is a genomic life scien...
MELBOURNE, Australia, Oct. 20, 2021 /PRNewswire/ -- Australian mid-clinical stage antiviral drug de...
SYDNEY, Oct. 6, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncolo...
* Zantrene® at low concentrations kills high FTO producing melanoma cancer cells * Sensitivity ...
SYDNEY, Sept. 30, 2021 /PRNewswire/ -- EZZ Life Science Holdings Limited (ASX: EZZ),a producer of c...
SYDNEY, Sept. 24, 2021 /PRNewswire/ -- Australian health and wellness company, EZZ Life Science Hol...
SYDNEY, Sept. 16, 2021 /PRNewswire/ -- SuperTrans Medical ("STM"), a biopharmaceutical company deve...
* HaemaLogiX completes a fully subscribed $10 million share placement and welcomes Platinum Ass...
Highlights: * AdAlta and Carina Biotech enter a collaboration agreement to develop i-body enable...
Openpay delivers continued strong growth in core business whilst setting the strategic foundations ...
SYDNEY, July 21, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a leadin...
* Capital raise nets $85 million from Existing Shareholders, Existing Institutional Investors, an...
* First patient dosed with QBiotics' lead oncology molecule tigilanol tiglate in combination with...